McLean Hospital Title:
- Director of Clinical Research, Schizophrenia and Bipolar Disorder Research Program
Harvard Medical School Title:
- Assistant Professor of Psychiatry
Ann K. Shinn, MD, MPH, is the director of clinical research in the Schizophrenia and Bipolar Disorder Research Program, and an assistant professor of psychiatry at Harvard Medical School. From 2013-2017, she was the co-medical director of McLean OnTrack, an intensive outpatient program specializing in the treatment of first episode psychosis. Her current research focus is in understanding the neurobiology of symptom dimensions in psychosis. She is the principal investigator of a federally funded research grant (K23 award) to investigate how auditory, speech, and language regions are connected in the brains of individuals with psychotic disorders who hear voices.
Dr. Shinn remains dedicated to improving the lives of individuals with psychosis, especially in early stages of illness. She teaches psychiatry residents about early psychosis. She also serves as an advisor to medical students in the Harvard-MIT Health Science and Technology MD Program. Dr. Shinn served as the McLean Hospital site co-director of the Harvard Medical School Psychopathology and Introduction to Clinical Psychiatry course from 2011-2014.
Dr. Shinn’s primary line of investigation is to better understand auditory hallucinations in psychotic disorders. While psychosis research has traditionally focused on diagnostic categories like schizophrenia, which are heterogeneous and may consist of multiple different though related disorders, Dr. Shinn has focused her investigations on a symptom dimension. She and her colleagues have provided additional evidence that auditory hallucinations—even “first-rank” auditory hallucinations, once considered to be pathognomonic of schizophrenia—are prevalent across disorders including schizophrenia, schizoaffective disorder, and psychotic bipolar disorder.
In related work, Dr. Shinn and her colleagues provided evidence in support of the DSM-5 Psychotic Disorders Work Group’s decision to eliminate the special treatment of first-rank auditory hallucinations (e.g., voices conversing or giving a running commentary) and bizarre delusions in the diagnostic criteria for schizophrenia. In this work, Dr. Shinn and collaborators showed that few patients receive a diagnosis of schizophrenia based on first-rank auditory hallucinations alone.
In addition to describing clinical features of voice hearing, she has contributed to insights about the neurobiology underlying auditory hallucinations. Building on the existing postmortem, structural MRI, and symptom capture fMRI literature suggesting that abnormalities of the primary auditory cortex are important in the pathogenesis of auditory hallucinations, Dr. Shinn studied whole-brain functional connectivity abnormalities associated with the primary auditory cortex, specifically left Heschl’s gyrus, in schizophrenia. In an extension of this work, Dr. Shinn and colleagues used machine learning of resting state fMRI to perform classification of schizophrenia patients with and without lifetime auditory hallucinations, showing that it is possible to discriminate the two groups with high accuracy. They showed that discrimination between patients with and without lifetime auditory hallucinations was highest, while discrimination between schizophrenia patients and healthy control participants was worst, suggesting that classification by auditory hallucinations may be more valid than discrimination based on traditional diagnostic categories.
Currently, Dr. Shinn is the principal investigator of a five-year NIH K23 Patient-Oriented Career Development Award to understand how the brain is functionally and structurally connected in patients who are prone to auditory hallucinations. The current work has the potential to provide deeper understanding of the pathophysiology underlying auditory hallucinations at the circuit level, including new knowledge about dynamic task-related aspects of brain connectivity in patients prone to auditory hallucinations. As of December 2018, participant recruitment and data collection are close to completion.
Dr. Shinn is also an investigator on a federally funded project (led by principal investigators Margaret Niznikiewicz, PhD, and Susan Whitfield-Gabrieli, PhD) to investigate the effect of real-time fMRI neurofeedback on engagement and modulation of the superior temporal gyrus, a region of the brain that plays a central role in auditory and language processing in schizophrenia patients with auditory hallucinations.
More recently, Dr. Shinn has collaborated with Milissa Kaufman, MD, PhD, and colleagues in McLean’s Dissociative Disorders and Trauma Research Program to explore auditory hallucinations—and voice hearing experiences more broadly—in individuals with trauma spectrum disorders, including post-traumatic stress disorder and dissociative disorders.
Dr. Shinn’s work also concerns investigations into abnormalities of the cerebellum in psychotic disorders. There is growing evidence that the cerebellum, which is reciprocally connected to higher-level association areas such as the prefrontal cortex, is involved in both non-motor as well as motor functions. Unlike most psychiatric neuroimaging studies that treat the cerebellum as a single homogeneous structure, she systematically investigated the topographic representations of cerebro-cerebellar resting state networks within the cerebellum in schizophrenia and found selective alterations in specific networks. Dr. Shinn and her collaborators conducted a similar study of cerebro-cerebellar functional connectivity also in individuals with bipolar disorder with psychotic features.
Currently, Dr. Shinn is conducting a pilot study in collaboration with transcranial magnetic stimulation (TMS) experts at Massachusetts General Hospital to investigate the effect of cerebellar stimulation on psychotic symptoms, including auditory hallucinations, in individuals with schizophrenia and bipolar disorder.
- Melissa Hwang, Research Assistant
- Sylvain Bouix, PhD, Brigham and Women’s Hospital
- Joan Camprodon-Gimenez, MD, PhD, MPH, Massachusetts General Hospital
- Bruce M. Cohen, MD, PhD, McLean Hospital
- Ev Fedorenko, PhD, Massachusetts General Hospital
- Milissa Kaufman, MD, PhD, McLean Hospital
- Hesheng Liu, PhD, Medical University of South Carolina
- Dara Manoach, PhD, Massachusetts General Hospital
- Margaret Niznikiewicz, PhD, VA Medical Center-Brockton
- Benjamin Reid, Brigham and Women’s Hospital
- Kerry J. Ressler, MD, PhD, McLean Hospital
- Martha Shenton, PhD, Brigham and Women’s Hospital
- Robert Stickgold, PhD, Beth Israel Deaconess Medical Center
- Susan Whitfield-Gabrieli, PhD, Northeastern University
- Sherry R. Winternitz, MD, McLean Hospital
Shinn AK, Baker JT, Lewandowski KE, Öngür D, Cohen BM. Aberrant cerebellar connectivity in motor and association networks in schizophrenia. Frontiers in Human Neuroscience 2015; 9:134.
Shinn AK, Roh YS, Ravichandran CT, Baker JT, Öngür D, Cohen BM. Aberrant cerebellar connectivity in bipolar disorder with psychosis. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 2017; 2(5): 438-448.
Shinn AK, Bolton KW, Karmacharya R, Lewandowski KE, Yuksel C, Baker JT, Chouinard VA, Pingali SM, Bye H, Cederbaum K, Öngür D. McLean OnTrack: A transdiagnostic program for early intervention in first-episode psychosis. Early Intervention in Psychiatry 2017; 11(1): 83-90.
Education & Training:
- 1998 BA, Columbia University
- 2001 MPH, UCLA School of Public Health
- 2005 MD, University of California San Francisco School of Medicine
- 2011 MMSc, Harvard Medical School
- 2005-2009 Psychiatry, Massachusetts General Hospital/McLean Hospital
- 2008-2009 Chief Resident, Schizophrenia and Bipolar Disorder Program, McLean Hospital
- 2009-2011 Clinical Investigator Training Program, Harvard-MIT Health Sciences and Technology/Beth Israel Deaconess Medical Center
- 2012-2014 The Stuart T. Hauser Clinical Research Training Program in Biological and Social Psychiatry, Judge Baker Children’s Center
- 2009 Medical License, Board of Registration in Medicine, Commonwealth of Massachusetts
- 2010 Psychiatry, American Board of Psychiatry and Neurology
Belmont campus - Admissions Building, Room S351